Medmix AG (XSWX:MEDX) COGS-to-Revenue : 0.68 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Medmix AG COGS-to-Revenue?

Medmix AG's Cost of Goods Sold for the six months ended in Dec. 2023 was CHF162.9 Mil. Its Revenue for the six months ended in Dec. 2023 was CHF238.5 Mil.

Medmix AG's COGS to Revenue for the six months ended in Dec. 2023 was 0.68.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Medmix AG's Gross Margin % for the six months ended in Dec. 2023 was 31.70%.

Medmix AG COGS-to-Revenue Historical Data

The historical data trend for Medmix AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medmix AG COGS-to-Revenue Chart

Medmix AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.61

0.66

0.60

0.63

0.68

Medmix AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial					0.61	0.60	0.66	0.67	0.68

Medmix AG COGS-to-Revenue Calculation

Medmix AG's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	329	/	486.6
	=	0.68

Medmix AG's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	162.9	/	238.5
	=	0.68

Medmix AG (XSWX:MEDX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Medmix AG's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	162.9 / 238.5
	=	31.70 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Medmix AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medmix AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medmix AG (XSWX:MEDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Medmix AG (XSWX:MEDX) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

MDMXF:USA MEDXz:UK

Address

Dammstrasse 19, Baar, Zug, CHE, 6340

Website

https://www.medmix.swiss

Medmix AG delivers technologies in high-precision delivery devices and fluid mixing for applications. It is into two business areas Healthcare and Consumer & Industrial. The Healthcare business area is divided into the Dental, Drug Delivery and Surgery segments. The Consumer & Industrial business area operates through the Industry and Beauty segments. The majority of revenue is from Consumer & Industrial segment. In the Industry segment, dispensers, cartridges, and mixers are used in the construction, transportation (automotive, railways and aerospace), electronics assembly, infrastructure and DIY industries. Geographically, it operates in Europe the Middle East and Africa, the Americas and Asia-Pacific.